Literature DB >> 33849965

Dose-Response Association between Adiposity and Liver Cancer Incidence: A Prospective Cohort Study among Non-Smoking and Non-Alcohol-Drinking Chinese Women.

Zhuo-Ying Li1,2, Hong-Lan Li2, Xiao-Wei Ji1,2, Qiu-Ming Shen1,2, Jing Wang2, Yu-Ting Tan2, Yong-Bing Xiang3,2.   

Abstract

BACKGROUND: Based on a population with very low prevalence of smoking and alcohol drinking, we examined the associations between overall obesity and fat distribution in middle age, obesity in early adulthood, and adult weight gain with the risk of liver cancer incidence.
METHODS: The associations between body mass index (BMI) at study enrollment and at age 20, waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), adult weight gain, and annual average weight gain with the risk of liver cancer were estimated using Cox regression models. Multivariable-adjusted HRs and 95% confidence intervals (CIs) were calculated.
RESULTS: After a mean follow-up time of 17.5 years, 241 liver cancer cases were identified from 69,296 participants. The HRs for per 5-kg/m2 increment of BMI, per 10-cm increment of WC and HC, and per 0.1-unit increment of WHtR in middle age were 1.29 (95% CI, 1.07-1.57), 1.23 (95% CI, 1.05-1.43), 1.30 (95% CI, 1.10-1.55), and 1.37 (95% CI, 1.07-1.75), respectively. The HRs for per 5-kg increment of absolute adult weight gain and per 0.5-kg/year increment of annual average weight gain were 1.15 (95% CI, 1.06-1.25) and 1.44 (95% CI, 1.08-1.92).
CONCLUSIONS: Overall and abdominal obesity in middle age and weight gain through adulthood were positively associated with liver cancer risk among non-smoking and non-alcohol-drinking women. IMPACT: Based on a cohort of non-smoking and non-alcohol-drinking women, the current study confirmed the association between obesity in middle age and increased liver cancer risk and suggested weight gain through adulthood as a risk factor for liver cancer. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 33849965      PMCID: PMC8172464          DOI: 10.1158/1055-9965.EPI-20-1610

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  25 in total

Review 1.  Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies.

Authors:  Yi Chen; Xiaolin Wang; Jianhua Wang; Zhiping Yan; Jianjun Luo
Journal:  Eur J Cancer       Date:  2012-03-23       Impact factor: 9.162

2.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

3.  Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults.

Authors:  Peter T Campbell; Christina C Newton; Neal D Freedman; Jill Koshiol; Michael C Alavanja; Laura E Beane Freeman; Julie E Buring; Andrew T Chan; Dawn Q Chong; Mridul Datta; Mia M Gaudet; J Michael Gaziano; Edward L Giovannucci; Barry I Graubard; Albert R Hollenbeck; Lindsey King; I-Min Lee; Martha S Linet; Julie R Palmer; Jessica L Petrick; Jenny N Poynter; Mark P Purdue; Kim Robien; Lynn Rosenberg; Vikrant V Sahasrabuddhe; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Victoria L Stevens; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Andrew G Renehan; Katherine A McGlynn
Journal:  Cancer Res       Date:  2016-10-15       Impact factor: 12.701

4.  Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.

Authors:  Jorge A Marrero; Robert J Fontana; Sherry Fu; Hari S Conjeevaram; Grace L Su; Anna S Lok
Journal:  J Hepatol       Date:  2005-02       Impact factor: 25.083

5.  Prospective cohort study of general and central obesity, weight change trajectory and risk of major cancers among Chinese women.

Authors:  Ying Liu; Shaneda Warren Andersen; Wanqing Wen; Yu-Tang Gao; Qing Lan; Nathaniel Rothman; Bu-Tian Ji; Gong Yang; Yong-Bing Xiang; Xiao-Ou Shu; Wei Zheng
Journal:  Int J Cancer       Date:  2016-05-31       Impact factor: 7.396

6.  Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort.

Authors:  Baiyu Yang; Jessica L Petrick; Scott P Kelly; Barry I Graubard; Neal D Freedman; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2017-04-26       Impact factor: 7.396

7.  Waist Circumference Might Be a Predictor of Primary Liver Cancer: A Population-Based Cohort Study.

Authors:  Luopei Wei; Ni Li; Gang Wang; Xiaoshuang Feng; Zhangyan Lyu; Xin Li; Yan Wen; Yuheng Chen; Hongda Chen; Shuohua Chen; Shouling Wu; Min Dai; Jie He
Journal:  Front Oncol       Date:  2018-12-12       Impact factor: 6.244

8.  Body mass index and weight change during adulthood are associated with increased mortality from liver cancer: the JACC Study.

Authors:  Yuanying Li; Hiroshi Yatsuya; Kazumasa Yamagishi; Kenji Wakai; Akiko Tamakoshi; Hiroyasu Iso; Mitsuru Mori; Fumio Sakauchi; Yutaka Motohashi; Ichiro Tsuji; Yosikazu Nakamura; Haruo Mikami; Michiko Kurosawa; Yoshiharu Hoshiyama; Naohito Tanabe; Koji Tamakoshi; Shinkan Tokudome; Koji Suzuki; Shuji Hashimoto; Shogo Kikuchi; Yasuhiko Wada; Takashi Kawamura; Yoshiyuki Watanabe; Kotaro Ozasa; Tsuneharu Miki; Chigusa Date; Kiyomi Sakata; Yoichi Kurozawa; Takesumi Yoshimura; Yoshihisa Fujino; Akira Shibata; Naoyuki Okamoto; Hideo Shio
Journal:  J Epidemiol       Date:  2013-04-20       Impact factor: 3.211

9.  Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults.

Authors:  Krishnan Bhaskaran; Ian Douglas; Harriet Forbes; Isabel dos-Santos-Silva; David A Leon; Liam Smeeth
Journal:  Lancet       Date:  2014-08-13       Impact factor: 79.321

10.  Central adiposity in relation to risk of liver cancer in Chinese adults: A prospective study of 0.5 million people.

Authors:  Yuanjie Pang; Christiana Kartsonaki; Yu Guo; Yiping Chen; Ling Yang; Zheng Bian; Fiona Bragg; Iona Y Millwood; Canqing Yu; Jun Lv; Junshi Chen; Liming Li; Michael V Holmes; Zhengming Chen
Journal:  Int J Cancer       Date:  2019-02-13       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.